Abstract:Over the last several decades, radiotherapy has been considered the primary treatment option for a broad range of cancer types, aimed at prolonging patients’ survival and slowing down tumor regression. However, therapeutic outcomes of radiotherapy remain limited, and patients suffer from relapse shortly after radiation. Neutrophils can initiate an immune response to infection by releasing cytokines and chemokines to actively combat pathogens. In tumor immune microenvironment, tumor-derived signals reprogram ne… Show more
“…There were reports suggesting that fractionated radiotherapy polarizes newly recruited neutrophils toward the antitumor N1 phenotype in the TME. 62 , 63 Our findings demonstrate that, similar to fractionated radiotherapy, the NQO1 bioactivatable drug β-Lap induces tumor-selective killing by polarizing tumor-infiltrated neutrophils into the antitumor N1 type.…”
Section: Discussionmentioning
confidence: 65%
“…It is noteworthy that low-dose and high-dose radiation have different effects on neutrophil polarization; understanding these differences may inform synergistic therapeutic strategies to enhance radiation therapy. 63 Furthermore, the antitumor subpopulation of neutrophils synergizes with PD-L1-based immunotherapy in a murine lung cancer model, modulating the protumor/antitumor neutrophil ratio and enhancing the antitumor function of a specific subset of neutrophils, and promotes T cell proliferation. 26 Understanding the plasticity and diversity of tumor-infiltrating or tumor-associated neutrophils is beneficial for assessing therapeutic efficacy.…”
“…There were reports suggesting that fractionated radiotherapy polarizes newly recruited neutrophils toward the antitumor N1 phenotype in the TME. 62 , 63 Our findings demonstrate that, similar to fractionated radiotherapy, the NQO1 bioactivatable drug β-Lap induces tumor-selective killing by polarizing tumor-infiltrated neutrophils into the antitumor N1 type.…”
Section: Discussionmentioning
confidence: 65%
“…It is noteworthy that low-dose and high-dose radiation have different effects on neutrophil polarization; understanding these differences may inform synergistic therapeutic strategies to enhance radiation therapy. 63 Furthermore, the antitumor subpopulation of neutrophils synergizes with PD-L1-based immunotherapy in a murine lung cancer model, modulating the protumor/antitumor neutrophil ratio and enhancing the antitumor function of a specific subset of neutrophils, and promotes T cell proliferation. 26 Understanding the plasticity and diversity of tumor-infiltrating or tumor-associated neutrophils is beneficial for assessing therapeutic efficacy.…”
“…Similarly, Toxic Epidermal Necrolysis (TEN), more than 30% of the skin surface involved in erosion of mucosae, occurs in a variety of diseases and shares similar symptoms with SJS (1)(2)(3)(4)(5). Both conditions represent severe drug-induced skin reactions that can be mediated by the immune response and have a high mortality rate observed in affected patients (6,7).…”
Rationale and patient concernsToxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are severe drug-induced skin reactions associated with a high mortality rate. The patient in this case report developed TEN after receiving the Velcade-lenalidomide-dexamethasone (VRD) regimen for the treatment of multiple myeloma (MM). The patient’s concerns included the progression of the rash, pain, itching, and potential long-term complications. TEN is a life-threatening condition that requires prompt medical intervention and hospitalization.InterventionsThe treatment approach for the patient included discontinuation of the causative medication (lenalidomide) and comprehensive supportive therapy. Supportive measures included the administration of systemic corticosteroids (methylprednisolone), intravenous immunoglobulin infusion, pain relief medication (ebastine), antibiotic prophylaxis, laminar bed use, and regular dressing changes. The goal was to alleviate symptoms, promote skin and mucous membrane healing, and prevent complications such as infection.DiagnosisThe patient was diagnosed with stage III A DS and stage III ISS MM, specifically of the immunoglobulin G (λ) type. Diagnostic procedures included CT and MRI scans, bone marrow testing through flow cytometry and morphology analysis, and laboratory tests to assess blood markers. The diagnosis of TEN was made based on the clinical presentation, skin biopsy, and exclusion of other potential causes.OutcomesWith the implemented interventions, the patient’s condition gradually improved, and the rash resolved without any residual scarring. The patient’s skin and mucosa healed, blood markers improved, and bone pain was relieved. The patient was discharged within a month of receiving the final treatment with bortezomib and dexamethasone. The patient got partial response(PR) of multiple myeloma.LessonsDrug-induced SJS/TEN is more prevalent in Asian populations, potentially due to differences in human leukocyte antigen (HLA) alleles. The use of systemic corticosteroid therapy in SJS/TEN cases is controversial due to the potential risks of immune suppression and complications. Balancing the immune response to prevent SJS/TEN while maintaining an effective cytotoxic immune response for tumor control remains a challenge. Lenalidomide, an immunomodulatory agent, can enhance antitumor immune responses but also contribute to the pathogenesis of SJS/TEN. Increased awareness of HLA variations and frequently mutated genes in different malignancies can help prevent SJS/TEN and improve patient outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.